The multifaceted roles of FOXM1 in pulmonary disease

• Main Authors: Yumei Li, Feng Wu, Qi Tan, Mengfei Guo, Pei Ma, Xuan Wang, Shuai Zhang, Juanjuan Xu, Ping Luo, Yang Jin
• Format: Article
• Language: English
• Published: BMC 2019-04-01
• Series: Cell Communication and Signaling
• Subjects: FOXM1; Transcriptional regulation; Cell cycle; Cell proliferation; Target therapy; Pulmonary disease
• Online Access: http://link.springer.com/article/10.1186/s12964-019-0347-1

Abstract Forkhead box M1 (FOXM1), a transcriptional regulator of G1/S and G2/M transition and M phase progression in the cell cycle, plays a principal role in many physiological and pathological processes. A growing number of studies have focused on the relationship between abnormal FOXM1 expression and pulmonary diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, acute lung injury (ALI), pulmonary fibrosis, and pulmonary arterial hypertension (PAH). These studies indicate that the FOXM1 regulatory network is a major predictor of poor outcomes, especially in lung cancer, and provide novel insight into various pulmonary diseases. For the first time, this review summarizes the mechanistic relationship between FOXM1 dysregulation and pulmonary diseases, the benefits of targeting abnormal FOXM1 expression, and the questions that remain to be addressed in the future.